Most of the layoffs may reportedly be from Cognizant’s subsidiary Trizetto’s office in Pune, which it acquired four years ago. Cognizant Technology Solutions (CTS) is said to be pruning its staff strength in some verticals such as healthcare and life…
Clinical trial shows alternate-day fasting a safe alternative to caloric restriction
In recent years there has been a surge in studies looking at the biologic effects of different kinds of fasting diets in both animal models and humans. These diets include continuous calorie restriction, intermittent fasting, and alternate-day fasting (ADF). Now…
CDSCO is blowin’ in the wind
In a letter addressed to Prime Minister Modi dated August 28, 26 manufacturers from the Punjab Drug Manufacturers Association (PDMA) have given details of the corrupt practices at the CDSCO/DCGI and its impact on the spirit of ‘entrepreneurship/ industry which…
CDER Warns Chinese, Indian Manufacturers
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) on Tuesday released two warning letters sent recently to India-based active pharmaceutical ingredient (API) manufacturer CTX Lifesciences Private Ltd and China-based drug manufacturer Ningbo Pulisi Daily…
Purdue Pharma Might Pay $10-12 Billion to Settle Opioid Lawsuits, File Bankruptcy
Purdue Pharma could be positioning itself to settle thousands of lawsuits related to the opioid crisis for a reported $10 to $12 billion. According to “people familiar with the matter,” the company and its owners, the Sackler family, are plotting…
Google is Now a Pharmaceutical Company
Big Tech has Merged with Big Pharma July 7, 2019 — Gary Null & Richard Gale have documented that Google now has a pharmaceutical division headed by GlaxosSmithKline’s former chairman of its global vaccine business. Null & Gale write: Google…
Regulatory Explainer: Everything You Need to Know About Biosimilars
For more than a decade now, biotech and pharmaceutical companies have brought a new class of treatments – biosimilars – to markets around the world (from the EU to India to South Korea to the US), offering cost savings for…
Regulatory Explainer: FDA’s Expanded Access (Compassionate Use) Program
What’s a Compassionate Use Program? Let’s back up for a quick moment: Under current US Food and Drug Administration (FDA) regulations, if a company wants to conduct a clinical trial on a drug, it first needs to obtain regulatory approval…
CDSCO Clarifies Rules on Importing Drugs for Use in Academic Clinical Trials
CDSCO has clarified the rules on organizations that want to import drugs for use in academic clinical trials. The regulator will waive the need to obtain an import license provided certain conditions are met. Under the New Drugs and Clinical…
Pfizer Investing $500 Million in North Carolina Gene Therapy Facility, Adding 300 Jobs
Pfizer announced it is putting an additional $500 million into the construction of its gene therapy manufacturing site in Sanford, North Carolina. It is planned to support the company’s investment in gene therapy research and development, much like its R&D…
